NOVO HOLDINGS US INVESTMENT ADVISOR, INC.

Thesis

Novo Holdings is a global life science investor managing assets for the Novo Nordisk Foundation, with a long-term perspective focused on generating attractive financial returns to support philanthropic goals in human health and sustainability. They invest across all stages of development in pharmaceuticals, biotechnology, medical technology, healthcare services, and industrial biosolutions. Their strategy includes seed investments in Scandinavia, venture investments in private and public companies (often leading rounds), growth capital for commercial-stage companies, principal investments in established firms, and planetary health investments for biosolutions with societal impact. They also have an Asia-focused investment strategy and manage a diversified portfolio of capital investments (equities, bonds, real estate, infrastructure, private equity) to balance risk. Novo Holdings operates globally with offices in Copenhagen, London, Boston, San Francisco, Singapore, Shanghai, and Mumbai, and has a flexible investment style, capable of taking majority or minority positions. As of year-end 2025, their AUM was approximately USD 109 billion. They aim to provide more than just capital, leveraging deep life science expertise and a global network.

Related lists

• Seed-stage Developer Tools investors
• Seed-stage Healthcare investors
• Series A Developer Tools investors